Lucila Kerbauy: Precision Medicine in AML and CAR Cells
Lucila Kerbauy, Head of Cell Therapy Center at Einstein Hospital Israelita, reposted from Larissa Zanetti, on LinkedIn:
“I’m very happy and proud to share another publication from our group on CAR-T cell therapy for acute myeloid leukemia (AML).
A special thank you to our team and collaborators who make this work possible. Advancing innovative and accessible cell therapies in Brazil and beyond is truly a collective effort.”
Quoting Larissa Zanetti’s post:
“It’s out!
I’m very proud to share our recent publication, “Precision Medicine in AML and CAR Cells: Where Are We?” — a collaborative effort uniting two leading research groups from our institution.
In this work, we explore how precision medicine and CAR-based cellular therapies (CAR-T and CAR-NK) are converging to transform the landscape of acute myeloid leukemia (AML) treatment. The review highlights the critical role of patient-specific approaches, novel target discovery, and next-generation cell engineering in shaping the future of personalized immunotherapy.
I truly believe that as the field of advanced cell therapies continues to expand, the integration of precision medicine principles will become increasingly essential.
A huge thank you to my incredible collaborators and mentors who made this work possible.”
Article: Precision medicine with car cells in acute myeloid leukemia: where are we?
Authors: Larissa C. Zanetti, Victoria Tomaz, Ingrid Ferreira de Souza, Paulo V. Campregher, Nelson Hamerschlak, Lucila N. Kerbauy
Read the full article here.
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms
-
Dec 16, 2025, 13:58AHA Awards Shubham Misra Postdoc Grant for LVO Stroke Biomarker Research
-
Dec 16, 2025, 13:00ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
-
Dec 16, 2025, 11:30Kingsley Wheaton: Sweden is on the Brink of Becoming the World’s 1st Smoke-Free Country
-
Dec 16, 2025, 11:03Matías J Alet on CABOS Project with The Support of WSO
-
Dec 16, 2025, 00:32New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
-
Dec 15, 2025, 23:36In a Time of Crisis: Dr. Amanda Rischbieth on Blood Donation, Solidarity, and Saving Lives